• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学决策模型中不确定性和患者异质性的综合分析。

The combined analysis of uncertainty and patient heterogeneity in medical decision models.

机构信息

Program for the Assessment of Radiological Technology, Departments of Radiology and Epidemiology, Erasmus MC, Rotterdam, The Netherlands (BGK, MGMH)

Department of Surgery, Gelre Ziekenhuizen, Apeldoorn, The Netherlands (BGK)

出版信息

Med Decis Making. 2011 Jul-Aug;31(4):650-61. doi: 10.1177/0272989X10381282. Epub 2010 Oct 25.

DOI:10.1177/0272989X10381282
PMID:20974904
Abstract

The analysis of both patient heterogeneity and parameter uncertainty in decision models is increasingly recommended. In addition, the complexity of current medical decision models commonly requires simulating individual subjects, which introduces stochastic uncertainty. The combined analysis of uncertainty and heterogeneity often involves complex nested Monte Carlo simulations to obtain the model outcomes of interest. In this article, the authors distinguish eight model types, each dealing with a different combination of patient heterogeneity, parameter uncertainty, and stochastic uncertainty. The analyses that are required to obtain the model outcomes are expressed in equations, explained in stepwise algorithms, and demonstrated in examples. Patient heterogeneity is represented by frequency distributions and analyzed with Monte Carlo simulation. Parameter uncertainty is represented by probability distributions and analyzed with 2nd-order Monte Carlo simulation (aka probabilistic sensitivity analysis). Stochastic uncertainty is analyzed with 1st-order Monte Carlo simulation (i.e., trials or random walks). This article can be used as a reference for analyzing complex models with more than one type of uncertainty and patient heterogeneity.

摘要

分析决策模型中的患者异质性和参数不确定性越来越受到推荐。此外,当前医学决策模型的复杂性通常需要模拟个体受试者,这引入了随机不确定性。不确定性和异质性的综合分析通常涉及复杂的嵌套蒙特卡罗模拟,以获得感兴趣的模型结果。在本文中,作者区分了八种模型类型,每种类型都处理不同的患者异质性、参数不确定性和随机不确定性组合。为了获得模型结果所需的分析以方程表示,以逐步算法解释,并通过示例演示。患者异质性用频率分布表示,并通过蒙特卡罗模拟进行分析。参数不确定性用概率分布表示,并通过二阶蒙特卡罗模拟(即概率敏感性分析)进行分析。随机不确定性用一阶蒙特卡罗模拟(即试验或随机游走)进行分析。本文可以用作分析具有多种不确定性和患者异质性的复杂模型的参考。

相似文献

1
The combined analysis of uncertainty and patient heterogeneity in medical decision models.医学决策模型中不确定性和患者异质性的综合分析。
Med Decis Making. 2011 Jul-Aug;31(4):650-61. doi: 10.1177/0272989X10381282. Epub 2010 Oct 25.
2
Uncertainty and patient heterogeneity in medical decision models.医学决策模型中的不确定性和患者异质性。
Med Decis Making. 2010 Mar-Apr;30(2):194-205. doi: 10.1177/0272989X09342277. Epub 2010 Feb 26.
3
Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.成本效益分析中的不确定性。概率不确定性分析与随机排名表。
Int J Technol Assess Health Care. 2002 Winter;18(1):112-9.
4
Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.需要速度:一种计算部分完全信息单参数期望值的高效算法。
Value Health. 2013 Mar-Apr;16(2):438-48. doi: 10.1016/j.jval.2012.10.018. Epub 2013 Jan 26.
5
Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.通过蒙特卡罗抽样算法计算完美信息的部分期望值。
Med Decis Making. 2007 Jul-Aug;27(4):448-70. doi: 10.1177/0272989X07302555.
6
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis.利用患者偏好权衡临床证据:概率多标准决策分析的应用
Pharmacoeconomics. 2017 Mar;35(3):259-269. doi: 10.1007/s40273-016-0467-z.
7
Handling uncertainty in cost-effectiveness models.处理成本效益模型中的不确定性。
Pharmacoeconomics. 2000 May;17(5):479-500. doi: 10.2165/00019053-200017050-00006.
8
Probabilistic biosphere modeling for the long-term safety assessment of geological disposal facilities for radioactive waste using first- and second-order Monte Carlo simulation.使用一阶和二阶蒙特卡罗模拟对放射性废物地质处置设施进行长期安全评估的概率生物圈建模。
J Environ Radioact. 2018 Oct;190-191:10-19. doi: 10.1016/j.jenvrad.2018.04.024. Epub 2018 May 15.
9
Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method.分析成本效益的决策模型中的不确定性:用非参数自助法评估增量成本与效益的联合分布。
Med Decis Making. 1998 Jul-Sep;18(3):337-46. doi: 10.1177/0272989X9801800312.
10
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.

引用本文的文献

1
Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations.通过将疾病停留密度计算为偏微分方程来评估半马尔可夫过程和其他流行病学事件发生时间模型。
Med Decis Making. 2025 Jul;45(5):569-586. doi: 10.1177/0272989X251333398. Epub 2025 May 8.
2
Patient-led home-based follow-up after surgery for colorectal cancer: the protocol of the prospective, multicentre FUTURE-primary implementation study.患者主导的结直肠癌术后家庭随访:前瞻性、多中心 FUTURE-初步实施研究方案。
BMJ Open. 2023 Oct 12;13(10):e074089. doi: 10.1136/bmjopen-2023-074089.
3
Quantifying the mental health and economic impacts of prospective Universal Basic Income schemes among young people in the UK: a microsimulation modelling study.
量化英国年轻人未来普遍基本收入计划对其心理健康和经济的影响:一项微观模拟建模研究。
BMJ Open. 2023 Oct 4;13(10):e075831. doi: 10.1136/bmjopen-2023-075831.
4
Estimation of the economic benefits for the public health system related to salt reduction in Costa Rica.估算哥斯达黎加减盐计划对公共卫生系统带来的经济效益。
PLoS One. 2023 Feb 17;18(2):e0279732. doi: 10.1371/journal.pone.0279732. eCollection 2023.
5
The estimated burden of ultra-processed foods on cardiovascular disease outcomes in Brazil: A modeling study.巴西超加工食品对心血管疾病结局的估计负担:一项建模研究。
Front Nutr. 2022 Nov 17;9:1043620. doi: 10.3389/fnut.2022.1043620. eCollection 2022.
6
Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis.估算巴西自愿减钠目标对健康和经济的影响:微观模拟分析。
BMC Med. 2021 Sep 29;19(1):225. doi: 10.1186/s12916-021-02099-x.
7
Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.用于支持国民保健制度健康检查计划决策的建模工具:研讨会、系统评价以及与用户的共同制作。
Health Technol Assess. 2021 May;25(35):1-234. doi: 10.3310/hta25350.
8
Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data.使用患者水平模拟模型推断临床试验数据时准确反映不确定性。
Med Decis Making. 2020 May;40(4):460-473. doi: 10.1177/0272989X20916442. Epub 2020 May 20.
9
FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.FDA 钠减排目标与食品行业:有激励措施进行配方改革吗?微观模拟成本效益分析。
Milbank Q. 2019 Sep;97(3):858-880. doi: 10.1111/1468-0009.12402. Epub 2019 Jul 22.
10
Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.美国食品和药物管理局添加糖标签政策改善饮食和健康的成本效益。
Circulation. 2019 Jun 4;139(23):2613-2624. doi: 10.1161/CIRCULATIONAHA.118.036751. Epub 2019 Apr 15.